https://orcid.org/0009-0003-2785-8779
References
- Lv W, Ruan Z, Zhang Q, et al. Serum Homer1 is a Novel Biomarker for Predicting the Clinical Outcomes of Acute Ischemic Stroke Patients. J Inflamm Res. 2024;17(February):1337–1347. doi:10.2147/JIR.S453018
- Fei X, Dou YN, Wang L, et al. Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage. J Neuroinflammation. 2022;19(1):1–18. doi:10.1186/s12974-022-02428-8
- Cui X, Liang H, Hao C, Jing X. Homer1 is a potential biomarker for prognosis in human colorectal carcinoma, possibly in association with g3bp1 signaling. Cancer Manag Res. 2020;12:2899–2909. doi:10.2147/CMAR.S240942
- Lv W, Wu X, Dou Y, et al. Homer1 Protects against Retinal Ganglion Cell Pyroptosis by Inhibiting Endoplasmic Reticulum Stress-Associated TXNIP/NLRP3 Inflammasome Activation after Middle Cerebral Artery Occlusion-Induced Retinal Ischemia. Int J Mol Sci. 2023;24(23):16811. doi:10.3390/ijms242316811
- Lv W, Zhang Q, Li Y, et al. Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation. Inflamm Res. 2024;73(1):131–144. doi:10.1007/s00011-023-01824-x